Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenQuadfi Booster Study in Adolescents Primed as Toddlers
NCT04936685Phase 3Active, not recruiting
- Sponsor
- Sanofi
- Start
- Aug 2022
- Primary completion
- Mar 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 4
01
Overview
A Phase 3 trial of meningococcal A conjugate vaccine in meningococcal infection, sponsored by Sanofi. Started Aug 2022; status: active, not recruiting.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT04936685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04936685.